Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Annals of Oncology
Published October 27, 2026
Prospective circulating tumour DNA surveillance in patients with early high-risk hormone receptor...
October 28, 2026
Medspoke
Medspoke
Hepatology
Published October 27, 2026
00:00
--:--
A pivotal Phase 2 study of derazantinib for previously-treated, locally advanced or metastatic ch...
October 28, 2026
Share
A pivotal Phase 2 study of derazantinib for previously-treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 aberrations: FIDES-01.
https://www.medspoke.co/channel_journal?id=785&tap_id=16450
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Cancer Discovery
Published October 27, 2026
CLDN18.2 ADCs "A Real Step Forward" for Stomach Cancer.
October 28, 2026
Why are you reporting this TALK?
